Feb 14 (Reuters) - Hologic Inc said on Tuesday that it would acquire medical aesthetics company Cynosure Inc for $1.65 billion.
Hologic, which focuses on women's health, agreed to pay $66 per Cynosure share, a premium of about 28 percent to its Monday close.
The transaction has an enterprise value of $1.44 billion, the companies said.
(Reporting by Natalie Grover in Bengaluru; Editing by Anil D'Silva)
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
The insurer was accused by a short-seller of "extensive" fraud.
(Bloomberg) -- Alphabet Inc.’s Google has fired 28 employees after they were involved in protests against Project Nimbus, a $1.2 billion joint contract with Amazon.com Inc. to provide the Israeli government and military with AI and cloud services.Most Read from BloombergDubai Grinds to Standstill as Cloud Seeding Worsens FloodingElon Wants His Money BackSingapore Loses ‘World’s Best Airport’ Crown to QatarRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingRed Lobster Considers Bank
Stock Market Today: The Dow Jones rose Thursday after initial unemployment claims. And Tesla stock hit a new low on a downgrade.
People with Roth IRAs generally have to wait five years before withdrawing earnings from their account. But the devil is in the details, and for this particular rule, getting those details can be surprisingly difficult. For starters, the IRS has three different five-year rules that apply to Roth IRAs. One of them, the conversion rule, […] The post My RMDs Start Soon So I Want to Convert $900k to a Roth, but I'm Getting Conflicting Info About Having to Wait 5 Years to Use the Money appeared first
These members of Congress delivered greater returns than Warren Buffett in 2023.
This stock is not without risk, but the potential upside more than offsets the headwinds.
People's wealth could take a huge hit as the stock market peaks after one of the longest bull markets ever, according to an investment chief.
The AI company is racking up new partnerships every week.
Vanguard funds are prized for their rock-bottom expense ratios and top performance. These three funds are among the company's best options in the large-cap growth arena.